230 related articles for article (PubMed ID: 9126326)
1. Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism.
Kobayashi T; Shinnoh N; Kondo A; Yamada T
Biochem Biophys Res Commun; 1997 Mar; 232(3):631-6. PubMed ID: 9126326
[TBL] [Abstract][Full Text] [Related]
2. Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein-deficient mice.
Yamada T; Shinnoh N; Kondo A; Uchiyama A; Shimozawa N; Kira J; Kobayashi T
Cell Biochem Biophys; 2000; 32 Spring():239-46. PubMed ID: 11330052
[TBL] [Abstract][Full Text] [Related]
3. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapy.
Netik A; Forss-Petter S; Holzinger A; Molzer B; Unterrainer G; Berger J
Hum Mol Genet; 1999 May; 8(5):907-13. PubMed ID: 10196381
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy.
Unterrainer G; Molzer B; Forss-Petter S; Berger J
Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720
[TBL] [Abstract][Full Text] [Related]
5. Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice.
Forss-Petter S; Werner H; Berger J; Lassmann H; Molzer B; Schwab MH; Bernheimer H; Zimmermann F; Nave KA
J Neurosci Res; 1997 Dec; 50(5):829-43. PubMed ID: 9418970
[TBL] [Abstract][Full Text] [Related]
6. Peroxisomal very long chain fatty acid beta-oxidation activity is determined by the level of adrenodeukodystrophy protein (ALDP) expression.
Braiterman LT; Watkins PA; Moser AB; Smith KD
Mol Genet Metab; 1999 Feb; 66(2):91-9. PubMed ID: 10068511
[TBL] [Abstract][Full Text] [Related]
7. X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.
Weinhofer I; Forss-Petter S; Kunze M; Zigman M; Berger J
FEBS Lett; 2005 Oct; 579(25):5512-6. PubMed ID: 16213491
[TBL] [Abstract][Full Text] [Related]
8. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.
Braiterman LT; Zheng S; Watkins PA; Geraghty MT; Johnson G; McGuinness MC; Moser AB; Smith KD
Hum Mol Genet; 1998 Feb; 7(2):239-47. PubMed ID: 9425230
[TBL] [Abstract][Full Text] [Related]
9. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.
Kruska N; Schönfeld P; Pujol A; Reiser G
Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114
[TBL] [Abstract][Full Text] [Related]
10. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
Kemp S; Wanders RJ
Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
[TBL] [Abstract][Full Text] [Related]
11. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
Singh J; Khan M; Singh I
J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
[TBL] [Abstract][Full Text] [Related]
12. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
[TBL] [Abstract][Full Text] [Related]
13. Protease inhibitors suppress the degradation of mutant adrenoleukodystrophy proteins but do not correct impairment of very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts.
Yamada T; Shinnoh N; Kobayashi T
Neurochem Res; 1997 Mar; 22(3):233-7. PubMed ID: 9051655
[TBL] [Abstract][Full Text] [Related]
14. Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes.
Contreras M; Sengupta TK; Sheikh F; Aubourg P; Singh I
Arch Biochem Biophys; 1996 Oct; 334(2):369-79. PubMed ID: 8900413
[TBL] [Abstract][Full Text] [Related]
15. Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy.
McGuinness MC; Lu JF; Zhang HP; Dong GX; Heinzer AK; Watkins PA; Powers J; Smith KD
Mol Cell Biol; 2003 Jan; 23(2):744-53. PubMed ID: 12509471
[TBL] [Abstract][Full Text] [Related]
16. Biochemical aspects of X-linked adrenoleukodystrophy.
Kemp S; Wanders R
Brain Pathol; 2010 Jul; 20(4):831-7. PubMed ID: 20626744
[TBL] [Abstract][Full Text] [Related]
17. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).
Genin EC; Geillon F; Gondcaille C; Athias A; Gambert P; Trompier D; Savary S
J Biol Chem; 2011 Mar; 286(10):8075-8084. PubMed ID: 21209459
[TBL] [Abstract][Full Text] [Related]
18. Adrenoleukodystrophy protein enhances association of very long-chain acyl-coenzyme A synthetase with the peroxisome.
Yamada T; Taniwaki T; Shinnoh N; Uchiyama A; Shimozawa N; Ohyagi Y; Asahara H; Kira J
Neurology; 1999 Feb; 52(3):614-6. PubMed ID: 10025797
[TBL] [Abstract][Full Text] [Related]
19. Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.
Engelen M; Schackmann MJ; Ofman R; Sanders RJ; Dijkstra IM; Houten SM; Fourcade S; Pujol A; Poll-The BT; Wanders RJ; Kemp S
J Inherit Metab Dis; 2012 Nov; 35(6):1137-45. PubMed ID: 22447153
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency.
Oezen I; Rossmanith W; Forss-Petter S; Kemp S; Voigtländer T; Moser-Thier K; Wanders RJ; Bittner RE; Berger J
Hum Mol Genet; 2005 May; 14(9):1127-37. PubMed ID: 15772093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]